Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — U.S. Border Patrol Agents Cautioned Against Using CBD Products

The U.S. Customs and Border Protection agency is warning its workers and their family members to say no to CBD. CBD (cannabidiol) is one of the two primary compounds found in marijuana. However, unlike THC, which induces a high when ingested, CBD does not.

In a recently published advisory, the agency highlighted some issues associated with this compound, highlighting that CBD products were still unregulated and could contain THC that can be detectable using a drug test.

It should be noted that the agency isn’t forbidding its workers from using CBD products derived from hemp, because the substance was legalized federally following the 2018 Farm Bill’s approval. However, the agency does strongly urge its agents to abstain from their use as a form of precaution.

In its advisory, the agency stated that its drug-free workplace plan mandated drug testing, which applied to all federal civilian employees. A positive drug test may result in disciplinary action and in extreme cases, removal from service. The advisory also observed that while some states had legalized the use of cannabis, THC and marijuana were still prohibited substances federally.

Currently, marijuana is classified as a Schedule I substances under the Controlled Substances Act. This is despite the fact that the recreational use of marijuana is legal in 22 states and Washington, D.C., while the medical use of the drug is legal in 38 states and the nation’s capital.

The federal agency elaborated on the warning, giving examples of research showing CBD products were sometimes mislabeled.

Given that the FDA is yet to establish regulations for these products, it is expected that the issue will persist. Earlier this year, the FDA announced that congressional action was needed to allow CBD be marketed as a dietary supplement or in food.

The recent advisory  by Customs and Border Protection comes after the human resources division at the U.S. Forest Service posted a notice in 2022 that also warned its employees about the risks of consuming CBD products that were federally unregulated.

Meanwhile, other federal agencies are reviewing their drug testing and employment policies, both for applicants and workers, amid the state-level legalization movement. Recently, the Secret Service relaxed restrictions on previous use of cannabis by prospective agents. The Bureau of Alcohol, Tobacco, Firearms and Explosives also recently updated its employment policy to not automatically disqualify applicants who had cultivated, manufactured or sold cannabis in compliance with state laws.

The warning by the border patrol agency clearly indicates that personnel should refrain from using cannabis-derived substances that aren’t federally regulated. This means that the products which companies such as IGC Pharma Inc. (NYSE American: IGC) take through the clinical-development process and obtain FDA approval wouldn’t be included in any advisory that federal agencies send to their employees.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Thai Cannabis Companies Say US-Grown Marijuana Is Threatening Their Businesses

Almost a year after the decriminalization of marijuana amid hopes of a boom in the economy, Thai cannabis cultivators and sellers allege that illegal imports from the United States that sell for a much lower price than the country’s buds are affecting their businesses. Thailand delisted marijuana from its list of prohibited substances in June of last year. This came about as a result of a significant effort by Anutin Charnvirakul, the health minister, to position the nation as a global powerhouse for medical marijuana.

However, the long-awaited marijuana bill has not yet been approved by Thailand’s parliament, which has left the industry’s regulatory structure in a state of uncertainty. Local companies claim that foreign capital is filling the funding void, with many shops around the nation promoting cheap cannabis that has been illegally imported from the United States.

Local marijuana operators argue that foreign brokers are approaching neighborhood dispensaries to market inexpensive, untaxed marijuana that is brought in at a discount and then sold for almost six times the original price.

Recreational marijuana use is still technically not allowed under Thailand’s law. But marijuana booths and shops can be spotted on most streets in major cities and towns due to the spotty regulation. Thai sellers and farmers are concerned that local companies are losing out on the increasing demand as visitors pour into Thailand to enjoy the country’s liberal attitude toward recreational marijuana use.

The Bhumjaithai political party, known for supporting decriminalization, attributes the influx of illegal imports to corrupt officials and political rivalry, which is creating unfavorable press coverage of marijuana reform in advance of upcoming general elections.

Supachai Jaisamutr, a proponent of marijuana legalization for the party, stated that despite the existence of legislation to deal with illegal imports, the officers from the agriculture and customs ministries who are in charge of implementing it do not do so. Supachai mentioned that according to estimates from the nation’s commerce chamber, the marijuana industry contributed roughly $1.2 billion to the economy in 2017. However, the financial advantages are difficult to see for many local stakeholders who are up against foreign capital.

One seasoned marijuana dealer who transitioned into a legal businessman claimed he spent a lot of money making his own fertilizer and soil only to discover that his marijuana was too pricey for a market flooded with low-cost imports.

Growers of marijuana in the United States have many resources available to them, including cultivation supplies such as those from Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment in our phase 2 clinical trial for epidermolysis bullosa, marking the first time cannabinol (‘CBN’) has completed a phase 2 clinical trial. We look forward to the data read out during 3Q and will then be in a better position to evaluate our strategic opportunities for the program,” said Eric A. Adams, president and CEO of InMed. “We are increasingly excited about the data we are seeing in our preclinical ocular and neurodegenerative disease programs where we are researching proprietary cannabinoid analogs in the treatment of various indications.”

To view the full press release, visit https://cnw.fm/zTFDv

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — CDC Study Reports Teen Cannabis Use Decreasing as Legalization Spreads

Recent federal data reveals that rates of marijuana usage among high school students have decreased even as more states legalize the drug. The Youth Risk Behavior Survey (YRBS) from the Centers for Disease Control and Prevention (CDC), which was released last week, indicated that teen usage of all substances tracked, including alcohol, prescription drugs and marijuana, has fallen linearly over the past 10 years.

The federal analysis reveals that marijuana use among high school kids was high between 2009 and 2013 — before legal cannabis outlets began to open — but it has since been generally declining. Voters passed the first state laws allowing for recreational use in 2012, and regulated retail sales started in 2014.

According to the most recent statistics from the biennial survey, 15.8% of high school students reported consuming marijuana at least once in the previous 30 days in 2021. This is a considerable decrease from 23.4% in 2013.

Health officials are encouraged by the trend, although they have noted that social isolation policies brought on by the coronavirus epidemic probably played a factor in how much juvenile substance abuse fell in the most recent two-year measurement period. Nevertheless, the general trend runs counter to one of the most popular prohibitionist justifications for opposing cannabis legalization. Despite their assertions, research and surveys, including federally funded ones, have repeatedly demonstrated that legalizing marijuana for adults will not increase teen use.

In fact, the YRBS survey found that marijuana use in high schools peaked in the years before any recreational cannabis dispensary was opened. And since then, as more and more marketplaces have opened up online, fewer young people now report consuming cannabis. Additionally, fewer teenagers claim to have ever used marijuana. In 2021, 27.8% of teenagers reported having used marijuana at least once in their lives, a decrease of more than 10% from the figure in 2019, which was 36.8%.

While COVID likely also played a role in the sudden fall in cannabis use observed in 2021, cannabis patterns have remained constant throughout the reform. For instance, research financed by NIDA and released in the “American Preventive Medicine Journal” last year revealed no correlation between the legalization of cannabis at the state level and a rise in juvenile use. According to the study, teenagers who used cannabis more frequently during adolescence had no increased or decreased likelihood of doing so at the age of 15 compared to those who used it less frequently or never.

As more companies such as IGC Pharma Inc. (NYSE American: IGC) register success in developing FDA-approved medicines from marijuana, it is possible that people will look at marijuana as a medicine, and juvenile use could decrease even further as access to these medicines is regulated through the healthcare system while recreational use is subject to age-verification in the states which permit adult-use marijuana.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Labor Peace Agreements May Be Good for the Marijuana Industry

Marijuana companies operate in rapidly changing and highly competitive environments, which means that labor disputes can considerably impact their business operations, leading to reputational damage, losses in revenue and even sanctions.

Labor peace agreements are agreements between bona fide labor organizations and a commercial marijuana licensee or license applicant. These agreements start a labor peace period where the employer agrees to not take part in actions that may undermine the ability of the union to organize the workforce while unions agree to not picket, strike or disrupt business operations in any other way.

The agreements also help promote long-term sustainability, social responsibility, productivity, stability and public safety in the marijuana industry by establishing a relationship between workers and employers. Additionally, collective bargaining facilitated by these agreements offer workers a voice in their workplaces, enabling them to negotiate for better working conditions, wages and benefits.

Collaborative relationships with workers also allow employers to recognize the value front-line workers bring to the table. This is in addition to obtaining valuable insights into the concerns and needs of their workforce and developing practices and policies promoting job satisfaction as well as productivity. This can, in turn, help improve morale, decrease turnover and improve overall productivity.

The establishment of labor peace agreements also allows employers to show their commitment to social responsibility and fair labor practices, helping promote economic and social equity in the industry while decreasing the risk of abuse and exploitation.

The marijuana industry’s workers need to be skilled and knowledgeable in various areas, including compliance, security and safety. These agreements help promote public safety by setting up standards for training and certification for workers. Some states in the country have already approved laws mandating safety training. More collaborations between employers, labor unions and workers will facilitate the development of training programs and standards for certification that ensure workers possess the skills and knowledge needed to perform their jobs effectively as well as safely.

Furthermore, as the marijuana industry grows and becomes more regulated, these agreements will provide a foundation for the burgeoning sector to develop in a way consistent with the values of economic and social equity, public safety and environmental responsibility.

All the above points support the use of labor peace agreements in this industry, at least as a first step in helping make sure that the cannabis sector is a source of well-paying and stable jobs for workers as well as a positive force in the communities it serves.

As stability is maintained in the way cannabis companies relate with their workers, operations could grow steadily as these companies focus on innovation to serve the evolving needs of customers. The new products can then attract more customers, which can create further downstream opportunities in the value chains of related companies such as Advanced Container Technologies Inc. (OTC: ACTX), which supplies equipment to grow marijuana indoors.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lift Toronto 2023 Cannabis Conference & Expo Connects Brands, Investors, Growers & Consumers from Across the Cannabis Industry

Cannabis industry growers, processors, manufacturers, brands, budtenders, retailers, educators, advocates, regulators, consumers, investors, and more, are invited to attend the Lift Toronto 2023 Cannabis Conference & Expo to be held June 1-3, 2023, at the Metro Toronto Convention Centre.

The three-day event will begin on Thursday, June 1, with the Lift Cannabis Business Conference (“LCBC”), an all-business strategy forum focused on generating meaningful change and sustainable growth within the Canadian cannabis industry. The conference will focus on the drivers of forward momentum, overcoming systemic challenges, and advancing innovative business and regulatory solutions. The LCBC sessions will include highlights such as keynotes and spotlight presenters, Canadian brands, world-view leadership panels, and more. Speakers will include industry leaders like Anna-Sophia Kouparanis, Co-Founder of the Bloomwell Group (Germany), Katy Perry, CEO of TOKE Cannabis, David Goldstein, CEO of Stoke Inventory Partners, and more.

“We are really pushing the envelope for our next trip to Toronto with top-tier presenters on red hot topics. Each session has been carefully curated to energize, inspire, educate, and motivate all of our audiences from across the entire cannabis community,” said Barry Smith, Canadian Content Director of Lift Events and Experiences.

Days two and three of the event will be Industry and Budtender Days and Consumer Day, respectively, at The Lift Expo tradeshow. Showcasing hundreds of leading and emerging exhibitors, the expo will also debut fresh experiences and activations, including games, photo opportunities, culinary cannabis trends, comedy performances, music, drinks, and more. In addition, multiple speakers, presentations, and panels on each of these two days will be featured on several stages placed throughout the expo floor. From the Main Stage to the East and West Speakers’ Corner Stages, carefully crafted content will inform and spark conversations that will drive the industry forward in the coming year.

Registration for the event is now open, with ‘early bird’ pricing available for a limited time. For more information on tickets and pricing, visit https://liftexpo.ca/tickets-toronto-2023/.

For more information on Lift Toronto 2023 and other Lift events, please visit https://liftevents.com/.  Cannabis Education Conferences & Exhibitions | Lift Events & Experiences (liftexpo.ca)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Bipartisan Bill to Seal Federal Cannabis Records Automatically

Bipartisan congressional legislators have reintroduced a measure mandating the automatic sealing of records for nonviolent federal cannabis convictions. The bill would also offer relief to individuals who’d been arrested for other offenses that didn’t end in conviction.

Representatives Nancy Mace and Lisa Blunt Rochester filed the Clean Slate Act last week. The previous version of the bill was advanced through the House Judiciary Committee in 2022 but was never voted on.

In a press release, Blunt Rochester stated that the Clean Slate Act was one of her top priorities, highlighting the importance of giving those who had paid their debt to society and served their time a second chance and a clean slate. Blunt Rochester added that she looked forward to working with her colleagues across the aisle and Congress to approve the bill and advance it to the president’s desk.

The measure would also set up a new process for individuals to petition the courts to seal records for nonviolent offenses that weren’t eligible for automatic sealing. If their initial request was denied, individuals could still petition for relief once a two-year wait period was over. Additionally, district courts will be allowed to nominate a public defender to help petitioners process their record sealing requests.

Mace stated that this measure was an important step in the right direction because it focused on rehabilitation and second chances.

Last year, President Joseph Biden issued a mass pardon for individuals who had committed federal marijuana possession offenses. However, this proclamation is limited, as presidential pardons don’t help seal conviction records.

The Mace measure is supported by various institutions, including R Street, the American Conservative Union, LinkedIn, Brennan Center for Justice, Justice Action Network (JAN), Center for American Progress, JPMorgan Chase, Code for America and Clean Slate Initiative.

Nan Gibson, the executive director of the JPMorgan Chase Policy Center, stated that the bill would establish a process for clearing nonviolent federal records and streamline it via automation, helping individuals pursue stable career opportunities. Gibson then noted that this bill would allow companies such as JPMorgan Chase to continue connecting people to meaningful career pathways, strengthening the economy and uplifting communities.

The Clean Slate Initiative CEO Sheena Meade stated that Congress had the power to unlock opportunities for millions of individuals in the country by approving the Clean Slate Act.

This bill is the latest in a string of cannabis reform measures that have been introduced in Congress.

While many reforms have been put before Congress over the past years, not many have made their way through the legislative chambers and reached the president’s desk for enactment. This slow pace at which marijuana policy is reformed could soon accelerate if many companies such as IGC Pharma Inc. (NYSE American: IGC) are successful in seeing cannabis-based medicines through the clinical development process resulting in FDA approval. Such drugs could cause people to reconsider their perceptions about marijuana and a lot more pressure for reform could be exerted on federal lawmakers.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Washington Governor Enacts Bill Authorizing Cannabis Interstate Commerce

Washington State’s governor has signed legislation allowing interstate marijuana trade in anticipation of a change in federal law. Governor Jay Inslee recently signed the bill introduced by Senator Ann Rivers into law after it passed the legislature last month.

Prior to approving the legislation, Inslee pushed Congress to update the country’s cannabis laws, arguing that legalization at the federal level would support the competitiveness of the highly regulated marijuana market while also upholding health and public safety requirements.

Once a federal law is changed or a federal Justice Department decision authorizing cannabis trading across state lines is passed, the legislation will permit the state to engage in interstate cannabis trade.

Now that this bill has been approved, all three states on the western coastline are ready to allow cannabis export and import. Oregon passed its bill in 2019 while California followed suit last year.

The Washington legislation stipulates that if one of the two federal conditions is satisfied, state authorities must provide written notice of the policy change and any state-level statutory amendments necessary to allow the delivery, sale and reception of marijuana from businesses out of the state. However, under California law, implementation could also begin without taking into account any conditions at the federal level.

Regulators in Washington will also be required to develop rules that will guide marijuana exports and imports. However, the governor will have sole authority to sign agreements with other states. Goods imported from out-of-state businesses would have to abide by Washington regulations, including labeling and packaging guidelines.

Meanwhile, a legislator from Maine has introduced a bill to permit marijuana exports and imports between states where it is legal. A comparable interstate plan was submitted by New Jersey’s senate president last year, but it hasn’t yet been approved.

Additionally, last year, a federal court ruled that the U.S. Constitution’s Commerce Clause made Maine’s law prohibiting nonresidents from running medicinal cannabis businesses in the state unlawful. Some commentators contend that the same logic used to support the residency restrictions also applies to state-level restrictions on marijuana import and export, rendering them invalid. There is also a belief that prohibiting medicinal cannabis imports and exports in states that have legalized it would be seen as both unconstitutional and protectionist.

A marijuana company from Oregon sued in a national court in November, claiming that the state’s current prohibition on interstate marijuana imports and exports is unconstitutional.

If cannabis interstate commerce becomes a reality around the country, states with favorable cultivation conditions could have a competitive edge and perhaps opt to use equipment such the microgardens sold by Advanced Container Technologies Inc. (OTC: ACTX) to produce more cost effectively and sell to states where climate and other conditions make it harder for marijuana to be grown.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by the Food and Drug Administration (“FDA”). Filling into capsules is expected to be completed this month. This will follow with analytical release and stability testing in order to gather essential quality control data necessary for Lexaria’s upcoming Investigational New Drug (“IND”) filing to the FDA, as previously agreed upon in last year’s successful pre-IND meeting as announced on Aug. 10, 2022.

To view the full press release, visit https://cnw.fm/FBr8V

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 30 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

BizCann Expo: An Elite Business & Networking Event for All Things Cannabis

BizCann Expo, a must-attend event for anyone working in the cannabis space, will be held in the city of Medellín, Columbia, May 20-21, 2023, a beautiful location surrounded by the spectacular Andes mountains. Colombia’s location an1d promising regulatory environment make it a rich location for the cannabis industry, with Medellin and nearby regions guiding its growth.

BizCann is the leading event in South and Latin America driving education, entrepreneurship, and innovation in all facets of the cannabis industry. Whether you’re a recognized canna-entrepreneur, or you are looking to join this exhilarating industry, BizCann Expo has all the resources you’ll need to connect to potential capitalists, find products, and launch your venture into a successful business.

BizCann Expo integrates the verticality of the cannabis industry, from seed to sale, in a safe space for entrepreneurship and learning. The expo welcomes plant-touching and non-plant-touching companies as well as ancillary services within the cannabis industry. The event lets the attendees showcase their business services, including innovative technologies and advanced products, to their potential customers and instantly make substantial gains. This event is for ages 18+ only.

Geared to ignite new business relationships

With 400+ exhibitors and a massive audience, the BizCann Expo is a must-visit event for all businesses hailing from the related industry verticals. This expo will focus on the prospects of the cannabis industry, and it attracts a wide range of participants, including business professionals, buyers, retailers, and end-users. They can avail amazing deals on the most popular CBD brands in the market.

The BizCann Expo will bring together the whole CBD and hemp business into one all-inclusive, comprehensive event, offering two days of seminars and workshops for attendees and industry professionals to learn about how cannabis improves health and wellness. Exhibitions will focus on the different cannabis benefits, and include the latest study on its use for treating different health conditions.

The BizCann Expo provides an opportunity to learn about the key elements of CBD and hemp from expert speakers. Licensed Producers, investors, growers, and suppliers can take advantage of networking opportunities and join like-minded industry professionals working in different aspects of the cannabis industry. It will help ensure their brands will prosper in the fast-growing cannabis business.

To learn more, please visit https://cnw.fm/jb0qM.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.